Skip to main content
Gain the Knowledge You Need to Successfully Trade Futures Markets
Our Technical Analysis Guide will give you the insight into today’s fast-moving markets. It’s designed to give you a head start in learning the basics of various TA tools and techniques.
Download Your Complimentary Technical Analysis Guide TODAY!
pixel

RAIN Insider Trading (Rain Therapeutics)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $29,199,000.00
Insider Selling (Last 12 Months): $0.00

Rain Therapeutics Insider Trading History Chart

Rain Therapeutics Share Price & Price History

$15.33
▲ +0.25 (1.66%)
As of 05/14/2021 01:00 AM ET
Days: 30 | 90 | 365
Learn How to Analyze Your Market and Trading Plan
Custom-design an options strategy to fit your market outlook. This guide goes beyond the basics to help you understand how to evaluate a strategy’s risk and reward. Start with your market outlook, then hone in on your strategy based on the risk you’re willing to take.
Download Your FREE Options Trading Strategy Guide today!
pixel

Rain Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/27/2021Boxer Capital, LlcDirectorBuy1,025,000$17.00$17,425,000.00View SEC Filing Icon  
4/27/2021Perceptive Advisors LlcMajor ShareholderBuy550,000$17.00$9,350,000.00View SEC Filing Icon  
4/23/2021Boxer Capital, LlcDirectorBuy150,000$16.16$2,424,000.00120,000View SEC Filing Icon  
See Full Table
Rain Therapeutics logo
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is RAIN-32, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing RAIN-32 that has completed Phase II clinical trial in liposarcoma, Phase I clinical trial in solid tumors, and Phase II clinical trial in intimal sarcoma, as well as RAD52 for tumors, including breast, ovarian, prostate, and other cancers. Rain Therapeutics Inc. was incorporated in 2017 and is headquartered in Newark, California.
Read More on Rain Therapeutics

Today's Range

Now: $15.33
$14.62
$15.88

50 Day Range

MA: N/A

52 Week Range

Now: $15.33
$14.08
$23.90

Volume

185,087 shs

Average Volume

209,406 shs

Market Capitalization

$398.10 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Rain Therapeutics?

Rain Therapeutics' top insider shareholders include:
  1. Boxer Capital, Llc (Director)
  2. Perceptive Advisors Llc (Major Shareholder)
Gain the Knowledge You Need to Successfully Trade Futures Markets
Our Technical Analysis Guide will give you the insight into today’s fast-moving markets. It’s designed to give you a head start in learning the basics of various TA tools and techniques.
Download Your Complimentary Technical Analysis Guide TODAY!
pixel